Your browser doesn't support javascript.
loading
Cytokinesis-block micronucleus assay adapted for analyzing genomic instability of human mesenchymal stem cells.
Cornélio, Déborah Afonso; Tavares, Joana Cristina Medeiros; Pimentel, Thais Valéria Costa de Andrade; Cavalcanti, Geraldo Barroso; Batistuzzo de Medeiros, Silvia Regina.
Afiliación
  • Cornélio DA; 1 Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte , Natal, Brazil .
Stem Cells Dev ; 23(8): 823-38, 2014 Apr 15.
Article en En | MEDLINE | ID: mdl-24328548
Human mesenchymal stem cells (hMSCs) are multipotent cells used in cell therapy research. One of the problems involving hMSCs is the possibility of genetic instability during in vitro expansion required to obtain a suitable number of cells for clinical applications. The cytokinesis-block micronucleus (CBMN) assay measures genetic instability by analyzing the presence of micronucleus (MN), nucleoplasmic bridges (NPBs), and nuclear buds (NBUDs) in binucleated cells. The present study describes modifications in the CBMN assay methodology to analyze genetic instability in hMSCs isolated from the umbilical vein and in vitro expanded. The best protocol to achieve binucleated hMSCs with preserved cytoplasm was as follows: cytochalasin B concentration (4.0 µg/mL), use of hypotonic treatment (3 min), and the fixative solution (9 methanol:1 acetic acid). These adaptations were reproduced in three hMSC primary cell cultures and also in XP4PA and A549 cell lines. The frequency of hMSCs treated with mitomycin-C presenting MN was lower than that with other nuclear alterations, indicating that the hMSCs contain mechanisms to avoid a high level of chromosomal breaks. However, a high frequency of cells with NPBs was detected and spontaneous anaphase bridges under normal hMSC in vitro culture were observed. Considering that anaphase bridges are characteristic alterations in tumor cells, the CBMN assay is indicated as an important tool associated with other genetic analyses in order to ensure the safe clinical use of hMSCs in cell therapy.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inestabilidad Genómica / Citocinesis / Células Madre Mesenquimatosas Tipo de estudio: Guideline Límite: Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: Stem Cells Dev Asunto de la revista: HEMATOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inestabilidad Genómica / Citocinesis / Células Madre Mesenquimatosas Tipo de estudio: Guideline Límite: Female / Humans / Male / Middle aged / Newborn Idioma: En Revista: Stem Cells Dev Asunto de la revista: HEMATOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos